申请人:ITM Isotopen Technologien München AG
公开号:US20220024882A1
公开(公告)日:2022-01-27
The present invention provides compounds according to General Formula (1)(i) or (1)(ii): wherein A is a diagnostic or therapeutic agent comprising a binding site for a tumor antigen, and the spacer comprises at least one C—N bond.